# Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer

> **NCT01396681** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** gemcitabine and cisplatin

## Key facts

- **NCT ID:** NCT01396681
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2011-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01396681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01396681, "Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01396681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*